OTC Markets Stock News
All posts tagged "CytoDyn Inc."
-
10.9KBiotechRISE of the COVID-19 Therapeutics CytoDyn (OTCMKTS: CYDY) & Humanigen (NASDAQ:HGEN)
Enrollment Key Metric in Therapeutic Race Philippines EUA Relevant to CytoDyn, not Humanigen Highly Credentialed Humanigen Team Possibility of NASDAQ Uplisting for...
-
11.7KBiotechCytoDyn (OTCMKTS: CYDY) Subtly Signals Pivot Into Philippines and Vaccine Market
On Sunday Night CytoDyn Inc. (OTCMKTS:CYDY) quietly placed a link in their developing news section to a 2016 medical journal article that...
-
5.4K1BiotechCytoDyn (OTCMKTS: CYDY) Accelerates Recruitment to 250 Patients in Pivotal COVID-19 Trial
CytoDyn Inc. (OTCMKTS:CYDY) on a conference call yesterday revealed that approximately 250 patients have been recruited in their CD12 severe to critical...
-
10.5KBiotechHandicapping CytoDyn’s (OTCMKTS: CYDY) Interim Readout
Powerful recommendation from DSMB Imminent on Leronlimab Numbers are not part of any Interim report unless a statistical penalty is taken A...
-
29.1K1BiotechCytoDyn’s (OTCMKTS: CYDY) Strong Safety Data in Mild to Moderate Smokes Gilead (NASDAQ: GILD) & Crushes Endpoint Leading to the First Potential COVID-19 Approval
CytoDyn Inc. (OTCMKTS: CYDY) announced groundbreaking safety results from its phase 2 Mild to Moderate COVID-19 trial today. The company reported a...
-
26.1KBiotechUK Prime Minister Boris Johnson Linkage to CytoDyn (OTCMKTS: CYDY) Evolving
CytoDyn Inc. (OTCMKTS: CYDY) announced today it was collaborating with the United Kingdom’s Department of Health to provide emergency access to leronlimab...
-
14.6KBiotechBACK TO WORK ORDER COMING – Courtesy of CytoDyn (OTCMKTS: CYDY)
Blood Race to Identify the COVID-19 Uninfected Cytodyn Inc. (OTCMKTS: CYDY) has a drug that could beacon the call back to work. ...
-
10.1KBiotechBioxtyran (OTCMKTS: BIXT) Licenses Phase 2 Asset for COVID-19 Patients After Finding Smoking Gun Journal Article
Bioxytran Inc. (OTCMKTS: BIXT) has a development stage hypoxia drug that that was initially targeting Acute Respiratory Distress Syndrome (ARDS) and stroke. ...
-
1.2KBiotechCytoDyn Inc (OTCMKTS: CYDY) Plotting A Comeback
CytoDyn Inc (OTCMKTS: CYDY) stock has posted impressive gains ever since the biotechnology company posted preclinical data showing its candidate drug Leronlimab...
